EDINBURGH, Scotland, Dec. 31, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T-cell therapies for cancer and other indications, today announced it has...
Read More Details
Finally We wish PressBee provided you with enough information of ( TCBP Provides Update on Acquisition Strategy and Current Targets )
Also on site :
- Which Stevie Nicks Song Matches You, Based on Zodiac Sign
- Met Office: Thunderstorm warning issued for parts of England in midst of 33C heatwave
- Pro-Palestinian activists break into UK military base